Recursion Provides Business Updates and Reports Third Quarter 2022 Financial Results

/PRNewswire/ -- Recursion (Nasdaq: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today reported business...

Related Keywords

Montreal ,Quebec ,Canada ,Salt Lake City ,Utah ,United States ,Toronto ,Ontario , ,Development Expenses ,Genentech ,Recursion Pharmaceuticals Inc ,Institutional Shareholder Services ,Chemical Technology ,Cavernous Malformation ,Adenomatous Polyposis ,Industrialized Validation ,Digital Tolerability ,Machine Learning ,Placement Offering ,Prime Rating ,Administrative Expenses ,San Francisco Bay ,Consolidated Statements ,Consolidated Balance Sheets ,Recursion ,